Statins for Cardiac and Vascular Protection During and After Cancer Therapy.
Statins for Cardiac and Vascular Protection During and After Cancer Therapy.
复制标题
DOI:
10.1007/s11912-022-01212-4
复制
发表时间:
2022-05
影响因子:
4.7
通讯作者:
中科院分区:
文献类型:
--
作者:
Although cancer treatments have increased overall survival rates, the cardiovascular consequences of cancer therapy place patients at an increased risk of adverse outcomes. This manuscript presents data accumulated to date regarding cardiovascular outcomes relating to the administration of 3-hydroxy-3-methylglutarylcoenzyme-A reductase inhibitor (or statin) therapy in individuals receiving potentially cardiotoxic cancer treatments. Retrospective observational studies in humans and randomized controlled trials in animals suggest that statins may reduce cancer-specific and all-cause mortality. Further, statins may attenuate cancer therapy-induced declines in left ventricular ejection fraction (LVEF) and increases in blood pressure. Observational studies suggest a potential attenuation in LVEF decline in patients with cancer and primary or secondary indications to receive a statin for prevention of cardiovascular events. Large randomized clinical trials are warranted to understand the efficacy and potential impacts of statin class, dosage, and duration on cardiovascular outcomes in patients treated for cancer.
登录
查看更多内容
DOI:
10.1016/j.cjca.2014.11.020
发表时间:
2015-03
期刊:
The Canadian journal of cardiology
影响因子:
--
作者:
Chotenimitkhun R;D'Agostino R Jr;Lawrence JA;Hamilton CA;Jordan JH;Vasu S;Lash TL;Yeboah J;Herrington DM;Hundley WG
通讯作者:
Hundley WG
影响因子:
5.2
作者:
Kwon H;Pessin JE
通讯作者:
Pessin JE
影响因子:
3.6
作者:
Climent E;Benaiges D;Pedro-Botet J
通讯作者:
Pedro-Botet J
影响因子:
4.8
作者:
Borahay, Mostafa A.;Kilic, Gokhan S.;Boehning, Darren
通讯作者:
Boehning, Darren
影响因子:
6.2
作者:
Calvillo-Arguelles, Oscar;Abdel-Qadir, Husam;Thavendiranathan, Paaladinesh
通讯作者:
Thavendiranathan, Paaladinesh